Grand Pharmaceutical Group Releases 2025 Annual Report and Shifts to Full Electronic Dissemination

Bulletin Express04-29

Grand Pharmaceutical Group Limited announced on 30 April 2026 that its latest Annual Report and accompanying Circular are now available in both English and Chinese on the company website (www.grandpharm.com) and the HKEXnews portal (www.hkexnews.hk). Printed copies will continue to be supplied free of charge upon request to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited.

Aligning with the paperless listing regime that took effect on 31 December 2023, the board confirmed adoption of electronic dissemination for all future corporate communications. Shareholders who prefer hard-copy documents can indicate this by returning the enclosed reply form or emailing grandpharma.ecom@computershare.com.hk.

Non-registered shareholders are urged to provide a functional email address to their custodial intermediaries—banks, brokers, custodians, nominees or HKSCC Nominees Limited—to ensure receipt of electronic notifications. Without a valid email on record, investors will need to monitor the company and HKEXnews websites proactively for new releases.

Enquiries can be directed to Computershare’s hotline on +852 2862 8688 during business hours. The notice is issued under the authority of Chairman Dr Tang Weikun on behalf of Grand Pharmaceutical Group’s board of directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1127723479?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-29 20:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1127723479","market":"us","top_or_hot":-1,"title":"Grand Pharmaceutical Group Releases 2025 Annual Report and Shifts to Full Electronic Dissemination","media":"Bulletin Express","content":"<p>Grand Pharmaceutical Group Limited announced on 30 April 2026 that its latest Annual Report and accompanying Circular are now available in both English and Chinese on the company website (www.grandpharm.com) and the HKEXnews portal (www.hkexnews.hk). Printed copies will continue to be supplied free of charge upon request to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited.</p>\n<p>Aligning with the paperless listing regime that took effect on 31 December 2023, the board confirmed adoption of electronic dissemination for all future corporate communications. Shareholders who prefer hard-copy documents can indicate this by returning the enclosed reply form or emailing grandpharma.ecom@computershare.com.hk.</p>\n<p>Non-registered shareholders are urged to provide a functional email address to their custodial intermediaries—banks, brokers, custodians, nominees or HKSCC Nominees Limited—to ensure receipt of electronic notifications. Without a valid email on record, investors will need to monitor the company and HKEXnews websites proactively for new releases.</p>\n<p>Enquiries can be directed to Computershare’s hotline on +852 2862 8688 during business hours. The notice is issued under the authority of Chairman Dr Tang Weikun on behalf of Grand Pharmaceutical Group’s board of directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grand Pharmaceutical Group Releases 2025 Annual Report and Shifts to Full Electronic Dissemination</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrand Pharmaceutical Group Releases 2025 Annual Report and Shifts to Full Electronic Dissemination\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-29 20:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Grand Pharmaceutical Group Limited announced on 30 April 2026 that its latest Annual Report and accompanying Circular are now available in both English and Chinese on the company website (www.grandpharm.com) and the HKEXnews portal (www.hkexnews.hk). Printed copies will continue to be supplied free of charge upon request to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited.</p>\n<p>Aligning with the paperless listing regime that took effect on 31 December 2023, the board confirmed adoption of electronic dissemination for all future corporate communications. Shareholders who prefer hard-copy documents can indicate this by returning the enclosed reply form or emailing grandpharma.ecom@computershare.com.hk.</p>\n<p>Non-registered shareholders are urged to provide a functional email address to their custodial intermediaries—banks, brokers, custodians, nominees or HKSCC Nominees Limited—to ensure receipt of electronic notifications. Without a valid email on record, investors will need to monitor the company and HKEXnews websites proactively for new releases.</p>\n<p>Enquiries can be directed to Computershare’s hotline on +852 2862 8688 during business hours. The notice is issued under the authority of Chairman Dr Tang Weikun on behalf of Grand Pharmaceutical Group’s board of directors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00512","symbol_name":"远大医药","start_time":0,"source_url":"","article_id":"1127723479","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1127723479","pubTimestamp":1777465460,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Grand Pharmaceutical Group Limited announced on 30 April 2026 that its latest Annual Report and accompanying Circular are now available in both English and Chinese on the company website...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00512":"远大医药"},"translate_title":"远大医药集团发布2025年年报转向全电子传播","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00512":1},"content_text":"Grand Pharmaceutical Group Limited announced on 30 April 2026 that its latest Annual Report and accompanying Circular are now available in both English and Chinese on the company website (www.grandpharm.com) and the HKEXnews portal (www.hkexnews.hk). Printed copies will continue to be supplied free of charge upon request to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited.\nAligning with the paperless listing regime that took effect on 31 December 2023, the board confirmed adoption of electronic dissemination for all future corporate communications. Shareholders who prefer hard-copy documents can indicate this by returning the enclosed reply form or emailing grandpharma.ecom@computershare.com.hk.\nNon-registered shareholders are urged to provide a functional email address to their custodial intermediaries—banks, brokers, custodians, nominees or HKSCC Nominees Limited—to ensure receipt of electronic notifications. Without a valid email on record, investors will need to monitor the company and HKEXnews websites proactively for new releases.\nEnquiries can be directed to Computershare’s hotline on +852 2862 8688 during business hours. The notice is issued under the authority of Chairman Dr Tang Weikun on behalf of Grand Pharmaceutical Group’s board of directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1127723479","isCrawlerRequest":true}